Active Studies - Center for Cancer Care & Research

When Cancer Strikes, Fight Back
If you are diagnosed with cancer, you will go to great lengths to beat it. And so do we at the Center for Cancer Care & Research. Fighting cancer is what we are all about. With experienced physicians you’ve known and trusted for years. Right in your community, not miles away. We’re affiliated with H. Lee Moffitt Cancer Center & Research Institute, which means that our patients have access to cutting edge research and treatment options. Our facility houses state-of-the-art equipment and technology – delivered with compassion from an expert team of cancer specialists. The Center for Cancer Care & Research. *Fighting for your life with the best care available.*
Support Links
	American Cancer Society
	Florida Cancer Trials
	Moffitt Cancer Center
	National Cancer Institute
	NCCN
	Oncology Nursing Society
	Support Groups

CLINICAL RESEARCH ACTIVE STUDIES

BREAST
BRE 133	Phase II study of Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER@-Negative Breast Cancer
NSABP B-43	A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
E5103	A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
PACCT-1 (TAILORx)	Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning IndividuaLized Options for Treatment: The TAILORx Trial-oncotype testing to determine breast cancer treatment.
BRE 145 (TITAN)	A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
GE JUNCTION AND STOMACH
GIST	Gastrointestinal Stromal Tumors (GIST) Registry Protocol
COLORECTAL
NSABP R-04	A Clinical Trial Comparing Preoperative Radiation Therapy with Capecitabine with or without Oxaliplatin with Preoperative Radiation Therapy and Continuous Intravenous Infusion of 5-Fluorouracil with or without Oxaliplatin in the Treatment of Patients with Operable Carcinoma of the Rectum
GENITOURINARY
GU 56	A Phase II Trial of Pazopanib in Patients with Metastatic Renal Cell Carcinoma Previously Treated with Sunitinib or Bevacizumab
HEMATOLOGIC
Amgen ITP	A Prospective, Phase IV, Open-Label, Multi-Center Study Evaluating Changes in Bone Marrow Morphology in Adult Subjects Receiving Romiplostim for the Treatment of Thrombocytopenia Associated with Immune (Idiopathic) Thrombocytopenia Purpura (ITP)
MCC 14978	A Phase II Study of Lenalidomide (REVLIMID®) in Combination with Rituximab for Patients with CD5+/CD20+ Hematologic Malignancies Who Relapse or Progress after Rituximab
LUNG
LUN 196 (TOPPS)	TOPPS: Trial Of Poor Performance Status patients. Randomized Phase II Trial of Pemetrexed vs. Pemetrexed/Bevacizumab vs. Pemetrexed/ Carboplatin/Bevacizumab in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer and ECOG Performance Status 2
MCC 15005	Randomized Phase III Multicenter Trial of RRM1 & ERCC1 Directed Customized Chemotherapy versus Standard of Care for 1^st Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer
HEAD AND NECK
LORHAN H&N	Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy other than Surgical Resection Alone for Newly Diagnosed Head and Neck Carcinoma
OVARIAN
CP15-0802	Randomized Phase II Trial Investigating Liposomal Doxorubicin with or without Anti-Platelet Derived Growth Factor Receptor-alpha (PDGFRa) Monoclonal Antibody IMC-3G3 in Patients With Platinum Refractory or Platinum-Resistant Advanced Ovarian Cancer
UNKNOWN ORIGIN
UNK PRI 20	A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients with Carcinoma of Unknown Primary Site
MICELLANEOUS
Bone Health Amg20060392	Prospective Multi-national Observational Study to Assess Health Resource Utilization Associated with Skeletal Related Events in Patients with Bone Metastases Secondary to Breast, Prostate, or Lung Cancer, or Multiple Myeloma
TCC – Total Cancer Care (MCC14690)	Total Cancer Care: A Partnership with High Risk and/or Diagnosed Cancer Patients for Life
Retrospective Studies	Radiofrequency Ablation
Retrospective Studies	Retrospective Chemotherapy Dose Accuracy Analysis Study
Retrospective Studies	Retrospective Breast Cancer Site Analysis, Quality, and Outcome Trial
FIQCC-P01 (MCC #15289)	Total Cancer Care: Florida Initiative for Quality Cancer Care Protocol (Colorectal)
FIQCC-P01 (MCC #15289)	Total Cancer Care: Florida Initiative for Quality Cancer Care Protocol (Breast)
FIQCC-P01 (MCC #15289)	Total Cancer Care: Florida Initiative for Quality Cancer Care Protocol (Lung)
FACTS	Facts and Attitudes about Clinical Trials

For More Information:

If you would like additional information about the Center for Research, please send your name, company or practice name, address and telephone number to the following address:

The Watson Clinic Center for Research
1600 Lakeland Hills Blvd
Lakeland, FL 33805
Attn: Noreen McGowan, BSN CCRC Administrative Coordinator
Phone 863-688-6826 · FAX 863-688-5842

Please indicate which of the following type(s) of information you would like:·

Additional information about current protocols
Center for Research grants
Contributing to Center for Research funding
Involvement in Center for Research protocols

ACTIVE STUDIES :: TARGETED THERAPIES

COLORECTAL